¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõÀ¯»êÈÄÇѾà ÇÑÀÇ¿ø °ÆÁ¤¸»°í

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#ÀÎõÀ¯»êÈÄÇѾà, #ÀÎõÀ¯»êÈÄÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»ê, #ÀÎõÀΰøÀ¯»ê, #À¯»êÈÄÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»êÇÑÀÇ¿ø, #ÀÎõÀΰøÀ¯»ê, #ºÎõÀ¯»êÈÄÇѾà ÀÎõÀ¯»êÈÄÇѾà,,ÀÎõÀ¯»êÈÄÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»ê,,ÀÎõÀΰøÀ¯»ê,,À¯»êÈÄÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»êÇÑÀÇ¿ø,,ÀÎõÀΰøÀ¯»ê,,ºÎõÀ¯»êÈÄÇÑ¾à ¾È³çÇϼ¼¿ä. ÀÎõÀ¯»êÈÄÇÑ¾à ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõÀ¯»êÈÄÇÑ¾à ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÀΰøÀ¯»ê, À¯»êÈÄÁ¶¸®, È­ÇÐÀûÀ¯»ê, À¯»êÈĺ¸¾à, È­ÇÐÀûÀ¯»ê»ý¸®, ÀڱüÒÆļú, ¼ÒÆļúÈÄ»ý¸®, ¼ÒÆļúÈĸöÁ¶¸®, ¼ÒÆļö¼úÈĸöÁ¶¸®, ÀÚ¿¬À¯»ê, À¯»êÈĸö°ü¸®, ÀÚ¿¬À¯»êÈĸöÁ¶¸®, °è·ùÀ¯»êÈĸöÁ¶¸®, ÀÓ½ÅÃʱâÀ¯»êÈÄ, È­ÇÐÀ¯»ê, À¯»êÈÄÇѾà, °è·ùÀ¯»êÇѾà, È­ÇÐÀûÀ¯»ê¸öÁ¶¸®, °è·ùÀ¯»ê, À¯»êÇѾà, È­ÇÐÀûÀ¯»êÇÏÇ÷, È­ÇÐÀûÀ¯»êÈÄÀÓ½Å, È­À¯, ÀΰøÀ¯»êÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»êÈÄ»ý¸®µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó SSP, Çѹ湰¸®¿ä¹ý, Àιٵð°Ë»ç, Àû¿Ü¼±Ä¡·á, ½Å°æ±Ùȸº¹¼ú, »ç»óüÁú°Ë»ç, ÅëÁõÄ¡·á±â, °æÇÇ°æ±ÙÇѳÿä¹ý, ºÀħ, Àιٵð, üÁßÁ¶Àý¿µ¾ç±³À°ÆÐÅ°Áö, ÇѹæÆĽº, Çâ±âÅõ°ú¿ä¹ý, ÇÖÆÑ, °æÇÇÀü±âÀڱؿä¹ý, cold therapy, NMES, ¸Æ¹Ý¼®¿Â½ÀÂòÁú±â, º¹Àâ±³Á¤Ãß³ª, ȯ¾à, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê µ¿·¡±¸ ¸íÀå1µ¿, Á¦ÁÖ Á¦Áֽà »ïµµÀ̵¿, ÃæºÏ º¸Àº±º º¸ÀºÀ¾, °æ³² â¿ø½Ã ¸¶»êȸ¿ø±¸ ÇÕ¼º1µ¿, °æ³² Å뿵½Ã µµ»ê¸é, ÀüºÏ ÀÍ»ê½Ã ¸ñõµ¿, °æ±â Çϳ²½Ã ±³»êµ¿, ÀüºÏ ÀÍ»ê½Ã ÀÍ»ê°ø´Ü¿ìü±¹»ç¼­ÇÔ, °æ³² ¾ç»ê½Ã Æò»êµ¿, °æºÏ »óÁֽà ³²À嵿, °æºÏ ¾Èµ¿½Ã ±æ¾È¸é, °æºÏ ¿µÃµ½Ã Àۻ굿, ºÎ»ê ºÏ±¸ ´öõ1µ¿, °æ³² Çϵ¿±º È­°³¸é, Ãæ³² °øÁֽà Á̵ֹ¿, °æ±â ±ºÆ÷½Ã ±ºÆ÷2µ¿, °­¿ø ö¿ø±º ±èÈ­À¾, ÀüºÏ ÀÍ»ê½Ã ºÎ¼Ûµ¿, °æºÏ ±èõ½Ã ºÎÇ׸é, °æ±â ºÎõ½Ã ¼Ò»ç±¸ °è¼öµ¿, Àü³² Áøµµ±º Á¶µµ¸é, ¼¼Á¾ ¾Æ¸§µ¿, ÀüºÏ ¼øⱺ º¹Èï¸é, °­¿ø ¼ÓÃʽà ´ëÆ÷µ¿, °æºÏ ¿µÁֽà âÁøµ¿, ÀüºÏ Á¤À¾½Ã Ä¥º¸¸é, Ãæ³² º¸·É½Ã ³»Ç×µ¿, Àü³² Çس²±º È­¿ø¸é, °æ³² ÁøÁֽà »çºÀ¸é, °­¿ø °­¸ª½Ã ÀԾϵ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõÀ¯»êÈÄÇѾàÄ¡·á ãÀ¸½Ã´Â ¸¸¼öµ¿, ÇÐÀ͵¿, ¿î³²µ¿, ¿µÈïµµ, ¿î¼­µ¿, Á¤¿Õµ¿, ½ÃÈ­, »óµ¿, ¼Ûµµ½Åµµ½Ã, ¼­Ã¢µ¿, µ¿ÀÎõ, ³íÇö°íÀܵ¿, ¿ëÇöµ¿, ¹è°ð, ¹è°ð½Åµµ½Ã, ¿Á·Ãµ¿, ÀÛÀüµ¿, ûÇе¿, Á־ȵ¿, ÀÎõ³íÇöµ¿, ÀÎõ³íÇö, µµ¸²µ¿, ¿¬¼ö±¸, ¼±Çе¿, ºñºÀ¸é, °Ë¾Ï, °£¼®µ¿, ¿µÁ¾µµ, °Ë´Ü, ÀÎõ¼­±¸, °ü±³µ¿, ºÎõ, ¼Ò·¡Æ÷±¸, °è¾ç±¸, °¡Áµ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Smith RP, Heltzel JA. Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report. J Reprod Med 1991; 36:260. 2. Norman RJ. Reproductive consequences of COX-2 inhibition. Lancet 2001; 358:1287. 3. Kerr J, Brown C, Balen AH. The experiences of couples who have had infertility treatment in the United Kingdom: results of a survey performed in 1997. Hum Reprod 1999; 14:934. 4. Muzii L, Bianchi A, Bellati F, et al. Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril 2007; 87:362. 5. Harel Z, Biro FM, Kollar LM. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. J Adolesc Health 1995; 16:379. 6. Pandey S, Maheshwari A, Bhattacharya S. Should access to fertility treatment be determined by female body mass index? Hum Reprod 2010; 25:815. 7. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98:511. 8. ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, et al. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010; 25:578.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõÀ¯»êÈÄÇѾà ÇÑÀÇ¿ø °ÆÁ¤¸»°í""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõ¼ÒÈ­ºÒ·® ´ãÀûº´ Ä¡·á °ÆÁ¤³¡
´ÙÀ½±Û ÀÎõÇÑÆ÷Áø ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
12 Áßµ¿ÇÑÀÇ¿ø ÃßõÇØ¿ä 2 6,943 2012-11-03
11 ºÎõ¿¡ ¶ó¿ÂÇÑÀÇ¿ø ÁÁ¾Æ¿ä 3 6,880 2012-11-03
10 Å°¿ì¹Ì ÇÑÀÇ¿ø ´Ù´Ï°í ÀÖ¾î¿ä 1 4,721 2012-11-01
9 ±¸¿ùµ¿¿¡ µ¿¿øÇÑÀÇ¿ø¿¡¼­ Ä¡·á¹Þ¾Ò¾î¿ä 5 15,236 2012-11-01
8 ½Å³ó¾¾ ÇÑÀÇ¿øÀÌ À¯¸íÇÑ °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. 3 17,064 2012-11-01
7 ¸í¿ÁÇå ÇÑÀÇ¿ø ÃßõÇص帳´Ï´Ù. 1 4,326 2012-11-01
6 ±Ý»êÇÑÀÇ¿ø, ±ÝÈ£µ¿¿¡ ÀÖ´Â ±Ý»êÇÑÀÇ¿øÀä 13 11,532 2012-10-29
5 ´õÆíÇѼ¼»óÇÑÀÇ¿ø, ¼Õ¹ßÀú¸²À̳ª °üÀýµîÀÇ ÁúȯÀ̽öó¸é µÐ»êµ¿ÀÇ ´õÆí.. 0 6,199 2012-10-29
4 ÇØÀκκÎÇÑÀÇ¿øÀ» ¼Ò°³Çص帱±î ÇÕ´Ï´Ù 1 8,076 2012-10-23
3 º´ÀÎÇÑÀÇ¿ø, Àú ¼Õ¹ß ¾öû Â÷°¡¿ü´Âµ¥ ¾È¾Ï¿ª º´ÀÎÇÑÀÇ¿ø°¡¼­ ³ª¾Ò¾î¿ä 0 4,761 2012-10-23
2 À¯ÀüÀûÀÎ ÇǺΠ¾Ë·¯Áö Ä¡·á 0 6,197 2012-10-23
1 Áö¼ºÇÑÀÇ¿ø, °­µ¿±¸ µÐÃ̵¿ ½ÃÀå¾Æ½Ã³ª¿ä? °Å±â¿¡ Áö¼ºÇÑÀÇ¿øÀ̶ó°í ÀÖ.. 13 38,842 2012-10-23
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷